This Viewpoint examines the potential use of machine learning to improve imaging-based breast cancer screening performance and associated patient outcomes.
http://ift.tt/2qDLFf2
http://ift.tt/2pCIrKC
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A 53-year-old man with a history of Crohn's disease on infliximab, presented with several weeks of cough and dyspnoea. He had a right-si...
-
Author: Stergiou, George S. MD, PhD; Ntineri, Angeliki MD, MSc; Kollias, Anastasios MD, PhD Page: 2481-2484 http://ift.tt/2rxEjKo h...
-
Calcitonin gene-related peptide (CGRP) is one of the most potent endogenous vasodilators identified to date. The present study elucidates th...
-
Abstract The silver palladium bimetallic core-shell structure nanoparticles (Ag@Pd NPs) were synthesized by a thin Pd shell slowly generat...
-
Author: Trelle, Alexandra N.; Henson, Richard N.; Green, Deborah A. E.; Simons, Jon S. DOI: 10.1037/xlm0000412 Publication Date: POST A...
-
Background: Clinically used antibiotics act through one of these four mechanisms: cell wall biosynthesis inhibition, inhibition of protein b...
-
Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap : Abstract Recent single institution clinical trial success...
-
Πέμπτη, 22 Ιουνίου 2017 Barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitisation A randomised t...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου